In addition, in the correlative studies described above, it is unclear whether these TIM-3 expressing cells significantly contribute to the immunosuppressive phenotype of glioma/glioblastoma patients or are a byproduct of the tumor progression. This evidence concerns the gene HAVCR2 and central nervous system cancer.